Skip to content

INTERCEPT™ Illuminator INT200

Designed for you, with you.

Improved Usability and Operational Efficiency in a Compact Footprint

The new INT200 was developed with input from the world's most experienced INTERCEPT users with the aim to maintain reliability and increase usability, with increased efficiency and smaller footprint when compared to the INT100.

Designed to meet your current and future pathogen inactivation needs while providing the highest quality requirements as outlined in the latest MDR*.

Using LED** lighting technology to treat platelets and plasma, the INTERCEPT Illuminator INT200 is the final step to implement a fully MDR* approved PI system for platelets and plasma.

 

* European Union Medical Device Regulation (2017/745). ** UVA light delivered by internal light-emitting diode (LED) sources

INT200 Front Left (low resolution)
Illuminator_TechOperation_March2024-2

Intuitive Design, Simplified Handling

The INT200 is designed to simplify operations, from start to finish, of the pathogen inactivation process

  • Touch Screen Navigation and Intuitive Software
  • Improved Tray Design 

  • Intelligent Scanning

  • Custom Reporting

Fits Right in with its Compact Design

The INT200’s contemporary vertical design results in improved workflow and ergonomics, freeing up space in your blood component lab. Fit three INT200 Illuminators in a comparable bench space as one INT100

 

INT200 Specifications:

Power: 120 VAC ~60Hz / 230 VAC ~50Hz. Maximum power consumption: 1390 W, not including peripherals

Measurements: H 70 cm (27.7’’), W 40 cm (15.9’’), D 77 cm (30.3’’)        

Weight: 66 kg (146 lbs)

Three INT200 (low resolution)
Illuminator_TechOperation_March2024-33 DEBRANDED

Streamlining Operational Steps for a Fast Work Flow

  • One illuminator for platelets and plasma
  • Fast bar code scanning
  • Two processing sets each illumination cycle

The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located.
Use of INTERCEPT Plasma or Platelets is contraindicated in patients with a history or allergic response to amotosalen or psoralens. Consult instructions for use for indications, contraindications, warnings, and precautions.

Cerus, INTERCEPT and the Cerus logo are trademarks of Cerus Corporation.

© 2023 Cerus Corporation. All Rights Reserved. MKT-EN 000157, v43.0